Home Infusion Therapy Market Size, Share, Growth Analysis, By Indication Analysis(Enteral Nutrition, Anti-Infective, Chemotherapy, Parenteral Nutrition), By Product Analysis(Devices, Drugs, Services), By Region - Industry Forecast 2024-2031

Home Infusion Therapy Market size was valued at USD 43.35 billion in 2019 and is poised to grow from USD 45.41 billion in 2023 to USD 65.2 billion by 2031, growing at a CAGR of 4.63% in the forecast period (2024-2031).

Infusion therapy services are also used to treat multiple sclerosis, rheumatoid arthritis, Crohn's illness, immunological deficiency, and hemophilia. Therefore, the growth of infusion therapy's application sectors offers tremendous opportunities for businesses to grow their services. This is expected to fuel the global market for infusion therapy.

An increase in the number of people with diabetes, cancer, and chronic pain is a key factor driving the global market for infusion therapy.

The International Agency for Research on Cancer (IARC) estimates that there will be 19.3 million new cases of cancer worldwide and 10 million cancer-related deaths in 2019, meaning that 1 in 5 people will develop cancer at some point in their lifetime and that 1 in 8 men and 1 in 11 women will pass away from the disease. The International Diabetes Federation (IDF) reports that there were 463 million individuals (20-79 years old) with diabetes worldwide in 2019, and that number is expected to reach 700 million by 2031. Additionally, 4.2 million people died from diabetes worldwide in 2019.

The infrastructure for healthcare is being modernized by governments in emerging nations, which is anticipated to expand access to healthcare. The need for infusion therapy services is anticipated to rise as a result. The worldwide infusion therapy industry has lucrative potential due to the rise in chronic disease prevalence in developing nations.

US Home Infusion Therapy Market is poised to grow at a sustainable CAGR for the next forecast year.